GSK plc GSK announced that the European Medicines Agency (“EMA”) has accepted for review a regulatory filing, seeking ...

The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

GSK’s application is underpinned by the positive outcomes from the Phase III MATINEE trial, which demonstrated a significant ...

The European Medicines Agency (EMA) has issued a warning about the dangers of unregulated advanced therapy medicinal products ...

The EU pharma legislation wants to turn paper leaflets in medication packaging into QR codes — driven by Big Pharma influence — but patients argue this change creates unnecess ...

March has shocked the rapeseed market, with China announcing 100% tariffs on Canadian rapeseed imports. Volatility is hitting ...

The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...

The crude oil markets look like they are taking a bit of a break after the big run higher on Thursday but are also seeing quite a few buyers step into them. At this point, the bottom looks to be in.

At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...

On the upside, a decisive break above the nine-day EMA could further strengthen short-term momentum, potentially driving ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...

CStone Pharma seeks EMA approval for sugemalimab to treat patients with unresectable stage III non-small cell lung cancer: Suzhou, China Tuesday, March 25, 2025, 17:00 Hrs [IST] C ...